Patent · US Active

CRISPR RNA targeting enzymes and systems and uses thereof

US11168322B2 · kind B2 · utility

0Cited by
1References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 8, 2018
Grant dateNov 9, 2021
Priority date
Expiry dateAug 19, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/20
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The disclosure describes novel systems, methods, and compositions for the manipulation of nucleic acids in a targeted fashion. The disclosure describes non-naturally occurring, engineered CRISPR systems, components, and methods for targeted modification of a nucleic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.